121 related articles for article (PubMed ID: 38114250)
1. Correction to "Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.".
Anaesthesia; 2024 Feb; 79(2):216-217. PubMed ID: 38114250
[No Abstract] [Full Text] [Related]
2. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
[TBL] [Abstract][Full Text] [Related]
3. Uterotonics in elective caesarean delivery: a randomised non-inferiority study comparing carbetocin 20 μg and 100 μg.
Tabl S; Balki M; Downey K; Tomlinson G; Farine D; Seaward G; Carvalho JCA
Anaesthesia; 2019 Feb; 74(2):190-196. PubMed ID: 30506558
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Trials; 2016 Mar; 17():155. PubMed ID: 27004531
[TBL] [Abstract][Full Text] [Related]
5. Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
Whigham CA; Gorelik A; Loughnan TE; Trivedi A
J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3866-9. PubMed ID: 26940081
[TBL] [Abstract][Full Text] [Related]
6. Carbetocin reduces the need for additional uterotonics in elective caesarean delivery: a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.
Onwochei DN; Van Ross J; Singh PM; Salter A; Monks DT
Int J Obstet Anesth; 2019 Nov; 40():14-23. PubMed ID: 31353178
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
[TBL] [Abstract][Full Text] [Related]
9. Room temperature stable carbetocin for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally: study protocol for a randomized controlled trial.
Widmer M; Piaggio G; Abdel-Aleem H; Carroli G; Chong YS; Coomarasamy A; Fawole B; Goudar S; Hofmeyr GJ; Lumbiganon P; Mugerwa K; Nguyen TM; Qureshi Z; Souza JP; Gülmezoglu AM
Trials; 2016 Mar; 17(1):143. PubMed ID: 26988231
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
11. A study protocol for the cardiac effects of a single dose of either oxytocin 2.5 IU or carbetocin 100 µg after caesarean delivery: a prospective randomized controlled multi-centre trial in Norway.
Bekkenes M; Jørgensen MM; Flem Jacobsen A; Wang Fagerland M; Rakstad-Larsen H; Solberg OG; Aaberge L; Klingenberg O; Steinsvik T; Rosseland LA
F1000Res; 2021; 10():973. PubMed ID: 34745566
[No Abstract] [Full Text] [Related]
12. Intramuscular oxytocin versus Syntometrine
van der Nelson H; O'Brien S; Burnard S; Mayer M; Alvarez M; Knowlden J; Winter C; Dailami N; Marques E; Burden C; Siassakos D; Draycott T
BJOG; 2021 Jun; 128(7):1236-1246. PubMed ID: 33300296
[TBL] [Abstract][Full Text] [Related]
13. Carbetocin vs. oxytocin at elective caesarean delivery: challenges and complexities in performing and interpreting a non-inferiority trial.
Hughes IP; Butler S
Anaesthesia; 2023 Oct; 78(10):1306-1307. PubMed ID: 37337425
[No Abstract] [Full Text] [Related]
14. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
[TBL] [Abstract][Full Text] [Related]
15. Carbetocin versus oxytocin in the management of atonic post partum haemorrhage (PPH) after vaginal delivery: a randomised controlled trial.
Maged AM; Hassan AM; Shehata NA
Arch Gynecol Obstet; 2016 May; 293(5):993-9. PubMed ID: 26511939
[TBL] [Abstract][Full Text] [Related]
16. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
Elbohoty AE; Mohammed WE; Sweed M; Bahaa Eldin AM; Nabhan A; Abd-El-Maeboud KH
Int J Gynaecol Obstet; 2016 Sep; 134(3):324-8. PubMed ID: 27350226
[TBL] [Abstract][Full Text] [Related]
18. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
19. Oxytocin agonists for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2007 Jul; (3):CD005457. PubMed ID: 17636798
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Oxytocin vs. Carbetocin Uterotonic Activity after Caesarean Delivery Assessed by Electrohysterography: A Randomised Trial.
Paljk Likar I; Becic E; Pezdirc N; Gersak K; Lucovnik M; Trojner Bregar A
Sensors (Basel); 2022 Nov; 22(22):. PubMed ID: 36433591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
